Runben Biotechnology Co., Ltd. (SHA:603193)
22.37
-0.18 (-0.80%)
At close: Mar 9, 2026
Runben Biotechnology Market Cap
Runben Biotechnology has a market cap or net worth of 9.05 billion as of March 9, 2026. Its market cap has decreased by -23.94% in one year.
Market Cap
9.05B
Enterprise Value
7.92B
Revenue
1.52B
Ranking
n/a
PE Ratio
29.47
Stock Price
22.37
Market Cap Chart
Since October 17, 2023, Runben Biotechnology's market cap has increased from 8.93B to 9.05B, an increase of 1.31%. That is a compound annual growth rate of 0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 9.05B | -7.68% |
| Dec 31, 2025 | 9.80B | 3.77% |
| Dec 31, 2024 | 9.45B | 28.44% |
| Dec 29, 2023 | 7.36B | -17.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Baiya Sanitary Products | 7.67B |
| C&S Paper Co.,Ltd | 11.05B |
| Guangdong Marubi Biotechnology | 11.19B |
| Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou | 6.78B |
| Hangzhou Haoyue Personal Care | 6.35B |
| Mingchen Health | 6.33B |
| Shanghai Jahwa United | 13.73B |
| Dencare (Chongqing) Oral Care | 5.92B |